Paper33015641
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.
Bovijn J and 2 others. Lancet Rheumatol, 2020. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19. Papers, record 33015641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33015641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FS/18/23/33512 | British Heart Foundation | United Kingdom | PubMed | |
| MC_UU_12026/2 | Medical Research Council | United Kingdom | PubMed | |
| MC_PC_14135 | Medical Research Council | United Kingdom | PubMed | |
| MC_UU_00017/1 | Medical Research Council | United Kingdom | PubMed | |
| MC_PC_13049 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22421340 | The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. | Lancet | 2012 | https://conductscience.org/library/papers/22421340 | PubMed |
| 2 | 32397738 | Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes: A Mendelian Randomization Study. | Circ Genom Precis Med | 2020 | https://conductscience.org/library/papers/32397738 | PubMed |
| 3 | 32404885 | The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. | Eur J Hum Genet | 2020 | https://conductscience.org/library/papers/32404885 | PubMed |
| 4 | 32838323 | Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study. | Lancet Rheumatol | 2020 | https://conductscience.org/library/papers/32838323 | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42009889 | Repurposing drugs for the prevention of vascular dementia using evidence from drug target Mendelian randomization. | Nat Aging | 2026 | https://conductscience.org/library/papers/42009889 | PubMed |
| 41969525 | Neuropeptide and cytokines expression in long COVID-19 related neuropsychological sequelae: insights into NK1R-mediated neuroinflammation and in silico therapeutic targeting. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/41969525 | PubMed |
| 41961272 | Proteome-wide Mendelian randomization identifies APOM and TNXB as actionable mediators of steroid-sensitive nephrotic syndrome. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/41961272 | PubMed |
| 41593342 | Explainable AI multiomics analysis reveals shared and divergent host responses in COVID-19 and influenza. | NPJ Digit Med | 2026 | https://conductscience.org/library/papers/41593342 | PubMed |
| 41402665 | Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry. | Nat Cardiovasc Res | 2025 | https://conductscience.org/library/papers/41402665 | PubMed |
| 40718904 | Human Genetics Informing Drug Development in Cardiovascular Disease: Interleukin-6 Signaling as a Case Study. | Circ Genom Precis Med | 2025 | https://conductscience.org/library/papers/40718904 | PubMed |
| 39944268 | Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges. | eGastroenterology | 2024 | https://conductscience.org/library/papers/39944268 | PubMed |
| 39622956 | Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis. | Sci Rep | 2024 | https://conductscience.org/library/papers/39622956 | PubMed |
| 39379679 | Disease coverage of human genome-wide association studies and pharmaceutical research and development. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/39379679 | PubMed |
| 39172202 | Causal factors for osteoarthritis risk revealed by mendelian randomization analysis. | Aging Clin Exp Res | 2024 | https://conductscience.org/library/papers/39172202 | PubMed |
| 39062668 | Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39062668 | PubMed |
| 38898459 | Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases. | J Transl Med | 2024 | https://conductscience.org/library/papers/38898459 | PubMed |
| 38789577 | CytoSIP: an annotated structural atlas for interactions involving cytokines or cytokine receptors. | Commun Biol | 2024 | https://conductscience.org/library/papers/38789577 | PubMed |
| 38550933 | Mendelian randomization as a tool to inform drug development using human genetics. | Camb Prism Precis Med | 2023 | https://conductscience.org/library/papers/38550933 | PubMed |
| 38198221 | PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations. | Eur J Prev Cardiol | 2024 | https://conductscience.org/library/papers/38198221 | PubMed |
| 38099246 | Host Genetic Impact on Infectious Diseases among Different Ethnic Groups. | Adv Genet (Hoboken) | 2023 | https://conductscience.org/library/papers/38099246 | PubMed |
| 37515388 | Germline mechanisms of immunotherapy toxicities in the era of genome-wide association studies. | Immunol Rev | 2023 | https://conductscience.org/library/papers/37515388 | PubMed |
| 37464031 | Biological and functional multimorbidity-from mechanisms to management. | Nat Med | 2023 | https://conductscience.org/library/papers/37464031 | PubMed |
| 36805566 | Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity. | Nat Metab | 2023 | https://conductscience.org/library/papers/36805566 | PubMed |
| 36801374 | The effect of interleukin-6 signaling on severe malaria: A Mendelian randomization analysis. | Int J Infect Dis | 2023 | https://conductscience.org/library/papers/36801374 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| IL6R | 3570 | PubTator's text mining | https://conductscience.org/library/genes/3570 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33015641
GET https://conductscience.org/api/papers/v1/33015641/cited_by?page=2